10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001564590-15-010627`
Period End Date	20150930
Filing Date	20151112
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	abio-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 37 Cash Flow Statement 50 Stockholders Equity 22

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.02M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.05M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.25M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$41.48M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.76M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$134.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.02M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$205.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.49M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$41.69M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$36.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$31.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$679.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$608.00K	USD	Point-in-time
Total assets	`Assets`	$42.40M	USD	Point-in-time
Total assets	`Assets`	$16.13M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$795.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$647.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$114.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$329.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$543.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$264.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.30M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$3.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.39M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.30M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at September 30, 2015 and December 31, 2014; 9,049,789 and 3,021,498 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at September 30, 2015 and December 31, 2014; 9,049,789 and 3,021,498 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$133.98M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$99.36M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-92.90M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-84.62M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$14.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$15.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$41.09M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$42.40M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$16.13M	USD	Point-in-time

Income Statement 37 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.33M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.04M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.17M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.10M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.04M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.11M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$950.00K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$2.29M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$7.08M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$8.28M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$2.82M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.29M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-8.28M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-7.08M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.82M	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$2.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$4.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$6.00K	USD	3 Qtrs
Interest and other income	`InterestAndOtherIncome`	$7.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$3.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.00K	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-9.69M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-2.81M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-7.08M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-2.28M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-8.28M	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.44	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.76	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.54	USD	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.03M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.00M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.90M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.36M	shares	3 Qtrs

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-9.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.28M	USD	3 Qtrs
Depreciation	`DepreciationAndAmortization`	$14.00K	USD	3 Qtrs
Depreciation	`DepreciationAndAmortization`	$8.00K	USD	3 Qtrs
Amortization of deferred charges	`AmortizationOfDeferredCharges`	$133.00K	USD	3 Qtrs
Amortization of deferred charges	`AmortizationOfDeferredCharges`	$34.00K	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$454.00K	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$491.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-147.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-132.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$452.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$229.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-232.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-167.00K	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-360.00K	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-215.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$229.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-72.00K	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-3.00K	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$2.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.53M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.91M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-5.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-9.00K	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$37.00M	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.04M	USD	3 Qtrs
Common stock offering costs	`PaymentsOfStockIssuanceCosts`	$2.76M	USD	3 Qtrs
Common stock offering costs	`PaymentsOfStockIssuanceCosts`	$834.00K	USD	3 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths`	$193.00K	USD	3 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths`	$179.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$34.05M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$8.03M	USD	3 Qtrs
Net increase in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$26.13M	USD	3 Qtrs
Net increase in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$493.00K	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$17.25M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$41.48M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$16.76M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$17.25M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$41.48M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$16.76M	USD	Point-in-time
Interest paid	`InterestPaid`	$3.00K	USD	3 Qtrs
Interest paid	`InterestPaid`	$4.00K	USD	3 Qtrs
Common stock offering costs accrued but not yet paid	`CommonStockOfferingCostsAccruedButNotYetPaid`	$69.00K	USD	3 Qtrs

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$14.74M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$15.58M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$41.09M	USD	Point-in-time
Beginning Balance, shares	`CommonStockSharesOutstanding`	3.02M	shares	Point-in-time
Beginning Balance, shares	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time
Issuance of common stock for cash, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$7.87M	USD	Annual
Issuance of common stock for cash, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$34.17M	USD	3 Qtrs
Issuance of common stock upon exercise of warrants for cash, value	`IssuanceOfCommonStockUponExerciseOfWarrantsForCashValue`	$338.00K	USD	Annual
Issuance of common stock upon vesting of Restricted Stock Units, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-2.00K	USD	Annual
Issuance of common stock upon vesting of Restricted Stock Units, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	3 Qtrs
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$647.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$454.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.28M	USD	3 Qtrs
Ending Balance	`StockholdersEquity`	$14.74M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$15.58M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$41.09M	USD	Point-in-time
Ending Balance, shares	`CommonStockSharesOutstanding`	3.02M	shares	Point-in-time
Ending Balance, shares	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.